Oils4cure: finding an effective drug to alleviate Refractory Epilepsy, one of th...
Oils4cure: finding an effective drug to alleviate Refractory Epilepsy, one of the most severe symptoms in the pathology of Tuberous Sclerosis
OILS4CURE is a Spanish biotech company dedicated to the research, development, production and commercialisation of medicinal products based on a medicinal cannabis extract. It is developing a drug to manage refractory epilepsy ass...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PANNEXIN
Pannexin 1 – a novel target for pediatric orphan epilepsy
4M€
Cerrado
EpiSen
Senolytics repurposing in childhood refractory epilepsies
150K€
Cerrado
IPT-2012-0561-010000
Desarollo de chaperonas farmacológicas para el tratamiento d...
759K€
Cerrado
IPT-2011-0861-900000
DESARROLLO PRECLINICO DE NUEVOS DERIVADOS CANNABINOIDES PARA...
657K€
Cerrado
G2B-002
GATE2BRAIN TOWARDS SME DESIGNATION AND PAEDIATRIC INVESTIGAT...
75K€
Cerrado
Información proyecto oils4cure
Duración del proyecto: 24 meses
Fecha Inicio: 2023-11-30
Fecha Fin: 2025-11-30
Líder del proyecto
OILS4CURE SL
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
2M€
Descripción del proyecto
OILS4CURE is a Spanish biotech company dedicated to the research, development, production and commercialisation of medicinal products based on a medicinal cannabis extract. It is developing a drug to manage refractory epilepsy associated with tuberous sclerosis (YCJ-01) and another for Leukodystrophies (YCJ-02), both are paediatric rare diseases. This project only deals with the development of our first and most advanced therapy directed at tuberous sclerosis (TS).